These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23745545)

  • 21. Epidemiology of proliferative diabetic retinopathy.
    Klein R; Klein BE; Moss SE
    Diabetes Care; 1992 Dec; 15(12):1875-91. PubMed ID: 1464243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes.
    Prescrire Int; 2010 Feb; 19(105):35-8. PubMed ID: 20455344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments.
    Heng LZ; Comyn O; Peto T; Tadros C; Ng E; Sivaprasad S; Hykin PG
    Diabet Med; 2013 Jun; 30(6):640-50. PubMed ID: 23205608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiology and natural history of diabetic retinopathy: an overview.
    Morello CM
    Am J Health Syst Pharm; 2007 Sep; 64(17 Suppl 12):S3-7. PubMed ID: 17720892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New concepts in pathogenesis and treatment of diabetic retinopathy.
    Spranger J; Pfeiffer AF
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S438-50. PubMed ID: 11460590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multifocal electroretinogram model predicting the development of diabetic retinopathy.
    Bearse MA; Adams AJ; Han Y; Schneck ME; Ng J; Bronson-Castain K; Barez S
    Prog Retin Eye Res; 2006 Sep; 25(5):425-48. PubMed ID: 16949855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and risk factors for diabetic retinopathy in a hospital-based population of Australian children and adolescents with type 1 diabetes.
    Keel S; Itsiopoulos C; Koklanis K; Vukicevic M; Cameron F; Brazionis L
    J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1135-1142. PubMed ID: 27658136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective.
    Sivaprasad S; Gupta B; Crosby-Nwaobi R; Evans J
    Surv Ophthalmol; 2012; 57(4):347-70. PubMed ID: 22542913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein(a) as a risk factor for diabetic retinopathy in patients with type 2 diabetes mellitus.
    Chopra R; Saramma JG; Mary J; Rebecca A
    Indian J Ophthalmol; 2007; 55(3):195-8. PubMed ID: 17456936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors for diabetic retinopathy].
    Sosna T; Svancarová R; Netuková M
    Vnitr Lek; 2013 Mar; 59(3):177-81. PubMed ID: 23713184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide mRNA analysis reveals a TUBD1 isoform profile as a potential biomarker for diabetic retinopathy development.
    Villegas-Ruiz V; Hendlmeier F; Buentello-Volante B; Rodríguez-Loaiza JL; Miranda-Duarte A; Zenteno JC
    Exp Eye Res; 2017 Feb; 155():99-106. PubMed ID: 28137601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology of diabetes mellitus and diabetic retinopathy.
    Sánchez-Thorin JC
    Int Ophthalmol Clin; 1998; 38(2):11-8. PubMed ID: 9604735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and factors associated with diabetic retinopathy in a Korean adult population: the 2008-2009 Korea National Health and Nutrition Examination Survey.
    Yang JY; Kim NK; Lee YJ; Noh JH; Kim DJ; Ko KS; Rhee BD; Kim DJ
    Diabetes Res Clin Pract; 2013 Dec; 102(3):218-24. PubMed ID: 24268633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis.
    Reiner AP; Agardh E; Teramura G; Gaur P; Gaur LK; Agardh CD
    Thromb Haemost; 2003 Jan; 89(1):142-8. PubMed ID: 12540964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology of diabetic retinopathy].
    Cantagallo A
    Ann Ig; 1989; 1(3-4):591-620. PubMed ID: 2483633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An update on diabetic retinopathy].
    Rechtman E; Harris A
    Harefuah; 2007 Nov; 146(11):872-7, 909. PubMed ID: 18087835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for diabetic retinopathy in Kuwaiti type 2 diabetic patients.
    Al-Adsani AM
    Saudi Med J; 2007 Apr; 28(4):579-83. PubMed ID: 17457481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of retinopathy progression in type 1 diabetes mellitus.
    Cohen RA; Hennekens CH; Christen WG; Krolewski A; Nathan DM; Peterson MJ; LaMotte F; Manson JE
    Am J Med; 1999 Jul; 107(1):45-51. PubMed ID: 10403352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.